EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic value of Node-RADS in predicting lymph node metastasis in endometrial cancer

Fatemeh Shakki Katouli, Fahimeh Zeinalkhani, Mohammad Hossein Hashemi, Fatemeh Nili, Rana Karimi, Reihaneh Mortazavi Ardestani, Elahe Basami, Shahrzad Sepidbar, Mahrooz Malek, Mohammadreza Tahamtan

Cancer Treatment and Research Communications · 2026 · 49 · 101464

DOI: 10.1016/j.ctarc.2026.101464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Fatemeh Shakki Katouli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran; Department of Radiology…. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Accurate assessment of lymph node (LN) status is essential for staging of endometrial cancer (EC). This study evaluated the diagnostic performance of the Node Reporting and Data System (Node-RADS) in predicting pelvic LN metastasis in EC using preoperative MRI. METHODS: In this retrospective study, patients with pathologically confirmed EC who underwent preoperative pelvic MRI between June 2020 and September 2025 were included. Node-RADS scores were assigned independently by two gynecologic radiologists in consensus and were correlated with surgical pathology. Diagnostic performance was assessed using receiver operating characteristic analysis. Area under the curve (AUC) values were compared using the DeLong test. Logistic regression was applied to identify independent predictors of LN metastasis. RESULTS: Among 169 lymph nodes in 72 patients, 21 (12.4%) were metastatic. Metastatic nodes demonstrated significantly higher Node-RADS scores and larger short-axis diameters (p < 0.05). Node-RADS was the strongest predictor of metastatic involvement (OR = 264, 95% CI: 16-41,330; p < 0.0001). Tumor ADC values independently correlated with nodal metastasis (OR = 0.984, 95% CI: 0.966-0.996; p = 0.005). Node-RADS demonstrated excellent diagnostic accuracy (AUC = 0.963; 95% CI: 0.910-1.000), significantly outperforming size-based assessment (AUC = 0.851; p = 0.0029). Using a cutoff of Node-RADS ≥ 3 yielded optimal performance, with a sensitivity of 85.7% and specificity of 98.0%. Increasing the cutoff to ≥ 4 achieved perfect specificity (100%) at the cost of reduced sensitivity (47.6%). CONCLUSION: MRI-based Node-RADS is a robust and highly accurate tool for predicting pelvic LN metastasis in EC, outperforming conventional size criteria and providing strong independent diagnostic value.

Schlagwörter

Stichwörter der Autor:innen

ADCDiagnostic accuracyEndometrial cancerLymph node metastasisMRINode-RADSPelvic lymph nodes

Autor:innen und Institutionen

  • Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran; Department of Radiology, Arash Women Hospital, Tehran University of Medical Sciences, Tehran,…
  • Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran; Department of Radiology, Tehran University of Medical Sciences, Imam Khomeini Hospital, Tehra…
  • Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Pathology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Obstetrics and Gynecology, Arash Women's Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Radiology, Medical Imaging Center, Imam Khomeini Hospital Complex (IKHC), Tehran University of Medical Sciences (TUMS), Tehran, Iran.

Zitieren

APA

Katouli, F. S., Zeinalkhani, F., Hashemi, M. H., Nili, F., Karimi, R., Ardestani, R. M., Basami, E., Sepidbar, S., Malek, M., & Tahamtan, M. (2026). Diagnostic value of Node-RADS in predicting lymph node metastasis in endometrial cancer. Cancer Treatment and Research Communications, 49, 101464. https://doi.org/10.1016/j.ctarc.2026.101464

Vancouver

Katouli FS, Zeinalkhani F, Hashemi MH, Nili F, Karimi R, Ardestani RM, et al. Diagnostic value of Node-RADS in predicting lymph node metastasis in endometrial cancer. Cancer Treatment and Research Communications. 2026;49:101464. doi:10.1016/j.ctarc.2026.101464

BibTeX
@article{Katouli2026,
  author = {Katouli, Fatemeh Shakki and Zeinalkhani, Fahimeh and Hashemi, Mohammad Hossein and Nili, Fatemeh and Karimi, Rana and Ardestani, Reihaneh Mortazavi and Basami, Elahe and Sepidbar, Shahrzad and Malek, Mahrooz and Tahamtan, Mohammadreza},
  title = {Diagnostic value of Node-RADS in predicting lymph node metastasis in endometrial cancer},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  volume = {49},
  pages = {101464},
  doi = {10.1016/j.ctarc.2026.101464}
}
Kostenlos starten →